CATALOGO DEI PRODOTTI DELLA RICERCA

Carbone, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.819
NA - Nord America 2.732
AS - Asia 1.860
SA - Sud America 244
AF - Africa 55
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.723
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.668
RU - Federazione Russa 1.002
SG - Singapore 661
CN - Cina 618
GB - Regno Unito 466
IT - Italia 377
DE - Germania 264
BR - Brasile 188
VN - Vietnam 187
HK - Hong Kong 183
FI - Finlandia 160
SE - Svezia 158
IE - Irlanda 128
FR - Francia 116
KR - Corea 57
NL - Olanda 33
CA - Canada 32
JP - Giappone 26
UA - Ucraina 26
TR - Turchia 24
AR - Argentina 21
IN - India 21
MX - Messico 20
ID - Indonesia 18
ES - Italia 17
BE - Belgio 15
ZA - Sudafrica 15
AT - Austria 14
PL - Polonia 12
BD - Bangladesh 11
JO - Giordania 10
NG - Nigeria 10
PY - Paraguay 9
AU - Australia 8
EC - Ecuador 8
CO - Colombia 7
MA - Marocco 7
BJ - Benin 5
IQ - Iraq 5
PH - Filippine 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
EG - Egitto 4
LT - Lituania 4
PK - Pakistan 4
TG - Togo 4
VE - Venezuela 4
CL - Cile 3
CR - Costa Rica 3
EU - Europa 3
GR - Grecia 3
HR - Croazia 3
KE - Kenya 3
PE - Perù 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.723
Salva come PNG Salva come JPEG
Città #
Southend 389
Chandler 357
Ashburn 356
Moscow 353
Singapore 346
Dallas 259
San Jose 228
Hong Kong 174
Verona 163
Woodbridge 152
Dublin 128
Munich 127
Jacksonville 125
Beijing 112
Helsinki 93
The Dalles 79
Ann Arbor 75
New York 54
Jinan 53
Ho Chi Minh City 51
Hanoi 43
Los Angeles 43
Houston 40
Wilmington 40
Lawrence 38
Princeton 38
Redmond 37
Nanjing 34
Shenyang 33
Tianjin 31
Council Bluffs 26
Tokyo 25
Hebei 24
Redondo Beach 22
São Paulo 22
Turku 21
Dong Ket 20
Santa Clara 18
Nanchang 17
Buffalo 16
London 16
Milan 16
Orem 16
Brussels 15
Frankfurt am Main 15
Haikou 15
Taiyuan 15
Guangzhou 14
Zhengzhou 14
Jakarta 13
Montreal 13
Seattle 13
Sindelfingen 13
Atlanta 12
Columbus 12
Johannesburg 11
Ningbo 11
Warsaw 11
Abuja 10
Boardman 10
Changsha 10
Lappeenranta 10
Bologna 9
Chennai 9
Chicago 9
Jiaxing 9
Madrid 9
Redwood City 9
Rio de Janeiro 9
Vienna 9
Amman 8
Brooklyn 8
Denver 8
Hangzhou 8
Kent 8
Washington 8
Amsterdam 7
Biên Hòa 7
Da Nang 7
Manchester 7
Mexico City 7
Norwalk 7
Nuremberg 7
Phoenix 7
Querétaro 7
San Francisco 7
Stockholm 7
Toronto 7
Ankara 6
Asunción 6
Barnet 6
Brasília 6
Haiphong 6
Jyväskylä 6
Paris 6
Seoul 6
Taizhou 6
Belo Horizonte 5
Boston 5
Cotonou 5
Totale 4.820
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 315
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 307
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 281
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 255
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 252
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 237
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 232
NF-κB as a target for pancreatic cancer therapy. 208
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 204
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 201
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 199
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 191
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 190
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 188
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 187
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 185
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 184
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 178
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 177
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 173
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 170
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 167
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 162
EMT and Treatment Resistance in Pancreatic Cancer 160
Local ablation disrupts immune evasion in pancreatic cancer 154
Molecular alterations in basal cell carcinoma subtypes 154
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 152
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 149
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 148
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 147
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 142
Toll-Like Receptor 9 Agonists for Cancer Therapy 142
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 140
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 134
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 130
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 127
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 124
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 123
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 118
Rationale and clinical use of multitargeting anticancer agents. 96
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 83
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 79
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 77
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 76
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 60
Totale 7.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.611
article - articoli 22.576
book - libri 0
conference - conferenze 1.310
curatela - curatele 0
other - altro 725
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 55 34 43
2021/2022436 40 150 17 37 11 5 8 24 9 12 19 104
2022/2023820 70 104 75 149 52 200 4 46 96 7 11 6
2023/2024491 13 22 36 54 52 71 27 77 6 35 73 25
2024/20251.292 51 55 51 174 55 78 120 88 213 78 117 212
2025/20263.255 212 161 286 552 876 219 315 170 266 198 0 0
Totale 7.809